Clinical Trial Update: Zotarolimus and Everolimus-Eluting Stents ProsPectively Compared in Real World [Phase 4]

View source ↗

Summary

Phase 4 clinical trial prospectively compares zotarolimus-eluting and everolimus-eluting stents in real-world patients with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Everolimus-eluting stent (everolimus-eluting stent)
• Zotarolimus-eluting stent (zotarolimus)

Snippet

Sponsor: Deutsches Herzzentrum Muenchen | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN